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Abstract
Background: Cats with hypertrophic cardiomyopathy (HCM) have decreased left
ventricular (LV) longitudinal deformation detected by mitral annular plane systolic
excursion (MAPSE) and speckle tracking echocardiography. People with preclinical
HCM have decreased systolic LV longitudinal and radial strain (S) and strain rate (SR),
with preserved circumferential S and SR.
Hypothesis/Objectives: Cats with preclinical HCM have decreased systolic LV defor-
mation compared to normal cats.
Animals: Seventy-three client-owned cats with (n = 37) and without (n = 36)
preclinical HCM.
Methods: Retrospective echocardiographic study. Left and right ventricular longitudi-
nal S and SR, LV radial and circumferential S and SR were calculated by STE. Left ven-
tricular mass was also calculated. Correlation between STE variables and LV
hypertrophy was determined and receiver-operating characteristic (ROC) curves
were plotted for prediction of HCM.
Results: Cats with HCM had smaller absolute longitudinal S (−14.8 ±3.3% vs
−19.7±2.7%, P< .001), longitudinal SR (−2.36±0.62 vs −2.95±0.68 second−1, P< .001),
radial S (46.2±21.3% vs 66.7±17.6%, P< .001), and radial SR (5.60±2.08 vs 6.67±1.8
second−1, P< .001) compared to healthy controls. No difference was observed for cir-
cumferential S and SR. Cats with HCM had greater LV mass (13.2 ±3.7 g vs 8.6 ±2.7 g,
P< .001). The ROC with the greatest area under the curve (AUC) for the identification
of HCM (0.974) was plotted from a logistic regression equation combining LV mass,
MAPSE at the free wall, and LV internal diameter in diastole (LVIDd).
Conclusions and clinical importance: Cats with preclinical HCM have decreased long
axis and radial deformation. Decreased longitudinal deformation and decreased
LVIDd are factors that would support a diagnosis of HCM.
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Abbreviations: IVSd, mean end-diastolic interventricular septal thickness; LA:Ao, left atrium to aorta ratio; LAD, left atrial diameter in long axis; LAFS, left atrial fractional shortening; LV mass,
end diastolic left ventricular mass; LV, left ventricular; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; LVFWd, mean end-diastolic left ventricular wall
thickness; LVIDd, end diastolic left ventricular internal diameter; MAPSE FW, mitral annular plane systolic excursion measured at the free wall; MAPSE IVS, mitral annular plane systolic excursion
measured at the interventricular septum; maxIVSd, maximal end-diastolic interventricular septal thickness; maxLVFWd, maximal end-diastolic left ventricular wall thickness; RVd, end diastolic
right ventricular wall thickness; S, strain; SR, strain rate; STE, speckle tracking echocardiography; TAPSE, tricuspid annular plane systolic excursion.
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1 | INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is the most common heart dis-
ease in cats, and is characterized by left ventricular (LV) hypertrophy
in the absence of abnormal loading conditions.1,2 Cats showing clinical
signs have high cardiac mortality rates, but the prognosis in cats with
preclinical HCM is highly variable.3–9
HCM is generally considered to be a disease of diastolic
impairment,10 with decreased systolic function (left ventricular fractional
shortening [LVFS]) being identified as a prognostic factor in cats with
HCM as a marker for late systolic impairment8; however, early systolic
impairment occurs with reduced LV longitudinal displacement (mitral
annular plane systolic excursion)11 and longitudinal myocardial deforma-
tion (longitudinal strain) both in people and cats with HCM.1,12–20
Speckle tracking echocardiography (STE) allows the quantification of
myocardial deformation in the longitudinal, radial, and circumferential
plane and can provide information on regional and global myocardial
function.21,22 STE appears to be a sensitive technique for the early diag-
nosis of HCM in people, and it has been used to differentiate left ven-
tricular hypertrophy because of HCM from athletes' heart, cardiac
amyloidosis, or storage disease. STE abnormalities have been docu-
mented in people with pathogenic HCM mutations who are phenotype-
negative based on conventional echocardiographic imaging.23–28
Reported applications for left ventricular STE in veterinary medicine
have included the investigation of dilated cardiomyopathy, tachycardia-
induced cardiomyopathy, degenerative mitral valve disease, and patent
ductus arteriosus.18,19,29–35 Three STE studies have reported investiga-
tions of cardiac mechanics in cats with HCM.18,19,36 One study showed
no difference in peak systolic longitudinal strain (S) and strain rate
(SR) in cats with asymptomatic HCM compared to healthy controls,
whereas another study showed reduced longitudinal and radial S in cats
with asymptomatic HCM compared with controls. Left ventricular wall
thickness was inversely correlated with longitudinal S, radial S and SR,
and circumferential S and SR.19The most recent study investigated mul-
tilayer STE in asymptomatic cats with dynamic outflow obstruction and
found lower longitudinal S and SR on all layers and an increased
epicardial-to-endocardial ratio in circumferential S and SR with pre-
served endocardial circumferential S when compared to healthy cats.36
Left ventricular (LV) wall thickness is the measurement most com-
monly used to diagnose HCM in both people and cats; however, it is a
relatively crude measure of hypertrophy and does not take into account
the overall distribution. Left ventricular mass can be calculated from
echocardiography and 1 study in people reported good correlation
between longitudinal S and LV mass.12,14 Left ventricular mass is not
routinely obtained in cats, although 1 study reported moderate correla-
tion between LV mass measured post-mortem (considered the gold
standard) with LV mass calculated by the truncated ellipse method from
2-dimensional (2D) echocardiography in cats with HCM.37
Because previous STE studies in cats have enrolled relatively
small, heterogeneous populations and found discordant results,
we sought to investigate whether cardiac mechanics in cats with pre-
clinical HCM were different compared to healthy control cats, and to
evaluate whether the magnitude of left ventricular hypertrophy corre-
lated with STE-derived variables. An additional aim of the study was
to identify the best logistic regression model that could aid in differen-
tiating cats with HCM from healthy controls using echocardiographic
indexes other than LV wall thickness.
Our hypotheses were that longitudinal and radial S and SR would
be lower in cats with HCM compared to healthy control cats, whereas
circumferential S and SR would not differ. We also hypothesized that
STE-derived variables would correlate with LV mass and that mea-
surements of longitudinal deformation and LV mass would be useful
in supporting a diagnosis of HCM.
2 | MATERIALS AND METHODS
The study received ethical approval from the Royal Veterinary College
(SR 2018-1559). The electronic database and echocardiography records
were reviewed for cats diagnosed with preclinical HCM between
April 2015 and September 2017. The control group comprised mainly
healthy cats undergoing cardiac assessment as part of a blood donor
program or cats in which a heart murmur had been auscultated but no
structural abnormalities had been identified on echocardiography.
Enrolment criteria were a complete case record (owner data,
cat signalment and history, complete physical examination) and a
complete echocardiographic examination. Cats were included in the
preclinical HCM group if the mean left ventricular wall thickness mea-
sured at end diastole was ≥6 mm for at least 1 myocardial segment
(at the interventricular septum or left ventricular free wall).3,4,7 Cats
were included in the healthy control group if no abnormalities were
detected on the echocardiographic examination and no systemic ill-
nesses that might affect hemodynamics or the cardiovascular system
were observed. Additional inclusion criteria were the presence of
good quality images with a minimum frame rate of 100 fps, and cine
loops to allow STE evaluation from a right parasternal short axis view
at the level of the papillary muscles, and a left apical 4 chamber view.
Additional requirements included a symmetric, circular LV cross-
section with minimal translational motion (“out-of-plane motion”) for
the short axis views, and long axis views excluding the LV outflow
tract, optimized for LV length and endocardial borders. When avail-
able, a cine loop from the left apical view optimized for longitudinal
right ventricular strain and strain rate was preferable but not neces-
sary for inclusion in the study.
Cats were excluded if there was a history compatible with conges-
tive heart failure; aortic thromboembolism; arrhythmias; receiving
medications; diagnosis of other conditions that could affect LV wall
thickness such as hyperthyroidism, systemic hypertension, acromeg-
aly, cardiomyopathies other than HCM, congenital heart disease, or
neoplastic disease. Cats were excluded for incomplete case records or
an inadequate echocardiographic examination. Left atrial enlargement
was not an exclusion criterion.
All echocardiographic examinations were performed using a com-
mercial ultrasound machine with 8-12MHz phased array ultrasound
probes (Vivid E95, GE systems, Hatfield, United Kingdom).
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All echocardiographic measurements represented an average of 3
measurements taken from different cardiac cine loops/still images
unless stated otherwise.Mean interventricular (IVSd) and free wall
(FWd) septal thickness were measured from a 2-dimensional right
parasternal long axis (2D RPLax) 4-chamber view at end diastole,
based on averaged thickness taken from 3 consecutive cardiac cycles.
Maximal interventricular (maxIVSd) and free wall (maxFWd) thickness
at end-diastole were measured as the mean value of 3 different
cardiac cycles taken from the thickest segment of 3 different views:
2D RPLax 4- or 5-chambered view or a short-axis view at the papillary
muscle level. End diastolic right ventricular wall thickness (RVd) was
measured from the RPLax 4-chamber view at end-diastole. Left ven-
tricular internal diameter in diastole (LVIDd) was also measured at end
diastole as an average from 3 2D RPLax 4-chamber view cine loops. A
leading edge to leading edge technique was used for IVSd, FWd, maxI-
VSd, maxFWd, RVd, and LVIDd. Left atrial size was assessed as left
atrium to aorta ratio (LA/Ao), which was measured from the right par-
asternal short axis view at the level of the heart base optimized for
the left atrium with a trailing edge to leading edge technique in the
first frame after aortic valve closure.7,10 Additionally, left atrial diame-
ter in long axis was measured from a right parasternal 4-chamber long
axis view by drawing a line parallel with the mitral annulus bisecting
the left atrium in the last frame before mitral valve opening.7 Left
atrial fractional shortening (LAFS) and left ventricular fractional short-
ening (LVFS) were measured with a leading edge to leading edge
method from M-Mode views of right parasternal short axis view at
the level of the heart base and papillary muscle, respectively, as previ-
ously described.7,38
The area-length method from the left apical 4-chamber view was
used to calculate left ventricular ejection fraction.38,39 LV mass was
calculated by the truncated ellipse method recommended in people
and previously applied in cats,37 with the apical 4-chamber view as
the reference long axis view.39
Mitral annular plane systolic excursion at the level of the free wall
(MAPSE FW) and interventricular septum (MAPSE IVS), as well as tri-
cuspid annular plane systolic excursion (TAPSE) were measured as
described.11
Speckle tracking postprocessing was performed off-line by 1
single, trained observer (IS). Commercial software was used for off-
line analysis (Echo Pac off-line measurement software, GE systems,
Hatfield, United Kingdom). The cine loop was evaluated frame
by frame to select a single frame as a starting point. Generally, the
software would automatically select end-systole, but the observer
assessed the whole cycle before selecting the best still frame. The
endocardium was tracked manually, after which a region of interest
was generated by the software, and was adjusted to fit the LV wall
thickness by the observer. The software automatically divided the
myocardium into 6 segments and evaluated tracking quality during
the cardiac cycle. The whole cine loop was further evaluated by the
operator and adjusted, if needed; only 1 manual attempt to adjust
endocardial points was considered acceptable. After this procedure, S
and SR curves were obtained by the software. Data were then
exported to an Excel data sheet and prepared for statistical analysis.
All echocardiographic values were measured 3 times on a single day
by the same operator based on a single-cycle clip/image and the results
shown are averaged. For advanced echocardiographic values, a global
peak systolic S and SR are provided, which are the averaged value of
the 6 regional segments identified by the software. Global IVS and
global LVFW S and SR were also calculated as the mean value of the 3
segments belonging to the IVS or FW. Right ventricular longitudinal S
and SR were calculated only at the RV free wall (3 segments) by using a
LV 4 chamber template and the interventricular values were discarded.
Circumferential and radial S and SR were measured from the right par-
asternal short axis view, whereas LV longitudinal S and SR were mea-
sured at the apical 4-chamber view, RV longitudinal S and SR, when
available, from a left apical view optimized for the RV. All S and SR
values were obtained from a mid-myocardium level. A within-day and
between-day coefficient of variation (CV) of both global and regional
strain and strain rate was assessed in 10% of the cats.
2.1 | Statistical analysis
Data were analyzed by a commercially available statistical software
(IBM SPSS Statistics version 22, IBM [UK] Ltd, Portsmouth, UK) and
statistical significance was set at P< .05. Continuous data were nor-
mally distributed according to the Shapiro-Wilk test. Data were there-
fore presented as mean± SD, except for body condition score, which
is an ordinal variable and was presented as median (range). In order to
compare healthy control cats with affected, a t-test was used for con-
tinuous variables, a chi-squared test was performed for categorical
variables, and Mann Whitney U test was applied for ordinal variables.
For the repeatability study, within-day and between-day coeffi-
cients of variation (CV) were calculated, including global and regional
CV. CV was calculated as the ratio between SD and mean×100.
Correlations between STE-derived variables and left ventricular
wall thickness were tested by the Pearson's correlation coefficient.
The correlation was considered perfect, strong, moderate or weak
when the value of the correlation coefficient (r) was 1, 0.7-0.9,
0.4-0.6, or 0.1-0.3, respectively.40 A receiver-operating characteristic
(ROC) curve with HCM (Y/N) as the predicting factor was performed
to identify the echocardiographic variables that would best classify
cats with HCM by methods other than left ventricular wall thickness
(gold standard). The area under the curve (AUC) was considered excel-
lent if the AUC was between 0.90 and 1, good for 0.80-0.90, fair for
0.70-0.80 and poor for 0.60-0.70.41 Cutoffs were also calculated and
the Youden Index: ([sensitivity + specificity]−1) was calculated to aid
in the identification of the optimal cutoff.
A binary logistic regression model with the presence of HCM
(Y/N) as the dependent variable was constructed. Potential explana-
tory variables were chosen using the values obtained from the ROC
analysis of all echocardiographic variables for which there were no
missing values. Variables with 95% confidence intervals for the AUC
that did not include the value 0.5 were considered for entry into the
model. The model was constructed in a forward stepwise manner.
Variables with the highest AUC were entered into the model first
and subsequent variables entered in descending order of AUC.
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Improvement of the model at each step was indicated by an increase
in the proportion of cases classified correctly. No more than 4 explan-
atory variables were entered in the model at any one time. In the final
model, only variables with P< .05 were retained. The sensitivity of the
final model to inclusion of previously excluded variables was evalu-
ated by individually adding back all excluded variables into the final
model. All variables entered into the model were checked for the risk
of collinearity. No pair of independent variables had an r-value of
greater than 0.8 in the correlation matrix. Goodness of fit of the
model was assessed using the Hosmer and Lemeshow test.
Predicted probabilities derived from the equation generated by
the final logistic regression model were used to plot an additional
ROC curve.42
3 | RESULTS
After case selection based on the inclusion criteria (Figure 1), the final
study population consisted of 73 cats: 36 healthy controls and 37 cats
with preclinical HCM. Mean age was 5.1 ± 3.5 years and mean body
cats with left ventricular
hypertrophy
(78)
final population analysed -
preclinical HCM (37)
cats showing clinical signs
(32)
cats on medication or with
diseases causing left
ventricular hypertrophy
(4)
poor quality / incomplete
echo (5)
cats without cardiac
abnormalities
(40)
poor quality / incomplete
echo (4)
final population analysed -
healthy controls (36)
F IGURE 1 Flow diagram showing
the selection process for cats with HCM
and healthy controls based on the
inclusion criteria. HCM, hypertrophic
cardiomyopathy
TABLE 2 Coefficient of variation for global and regional speckle tracking echocardiography variables
Circ S Circ SR Rad S Rad SR Long S Long SR RV Long S RV Long SR
Global within day 4% 6% 11% 13% 4% 6% 5% 10%
Global between day 5% 8% 9% 7% 4% 6% 4% 12%
Regional within day 9% 12% 12% 11% 8% 14% 6% 15%
Regional between day 9% 13% 13% 15% 11% 16% 11% 17%
Abbreviations: Circ S, circumferential strain; Circ SR, circumferential strain rate; Long S, longitudinal strain; Long SR, longitudinal strain rate; Rad S, radial
strain; Rad SR, radial strain rate; RV Long S, right ventricular longitudinal strain; RV Long SR, right ventricular longitudinal strain rate.
Coefficient of variation for advanced echocardiographic parameters.
TABLE 1 Baseline demographics of asymptomatic cats with HCM and healthy controls
Healthy controls (n = 36) HCM (n=37) P value
Age (years) 5 ± 3.4 5.3 ± 3.7 0.75
Sex (% male) 75% (27/36) 70% (26/11) 0.47
Breed (% non-pedigree) 69.4% (25/36) 56.7% (21/37) 0.27
Weight (kg) 4.7 ± 1.1 4.5 ± 1.1 0.48
Body condition score (1-9) 5 (3-8) 5 (2.5-7) 0.96
Data presented as mean±SD or as a percentage (for categorical data), or median (range) for ordinal variable (body condition score). To identify any difference
between groups, T-test was performed for continuous variables, chi-square for categorical variables, and Mann-Whitney-U test for ordinal variables.
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weight was 4.6 ± 1.2 kg with no difference between groups. Most
cats were male (54/73), with no difference in proportion of male cats in
the 2 groups. The majority of cats were domestic shorthair (46/73),
followed by domestic longhair (6/73), Maine Coon, Sphynx and
British Shorthair (5/73 each), Bengal (4/73), Devon Rex (3/73),
Russian White and Ragdoll (2/73 each). No difference between the
proportion of pedigree/ non-pedigree cats was found in the 2 groups
(Table 1).
Within-day and between-day CV of STE-derived variables showed
overall acceptable results, with greater variability on the regional S
and SR compared to global S and SR (Table 2).
TABLE 3 Standard echocardiographic variables in asymptomatic
cats with HCM and healthy controls
Clinical and
echocardiographic
parameters
Healthy
controls
(n = 36)
HCM
(n =37)
P value for
comparison
between groups
Heart Rate (bpm)
n = 73
179 ± 25 179 ± 28 .99
IVSd (mm)
n = 73
4.3 ± 0.4 6.8 ± 0.8 N/A
LVFWd (mm)
n = 73
4.3 ± 0.5 6.3 ± 1.3 N/A
Max IVSd (mm)
n = 73
4.5 ± 0.5 7.3 ± 0.8 N/A
Max LVFWd (mm)
n = 73
4.3 ± 0.6 6.5 ± 1.3 N/A
LVIDd (mm)
n = 73
14.9 ± 1.9 12.4 ± 1.9 <.001
RVd (mm)
n = 73
2.1 ± 0.4 2.5 ± 0.4 <.001
LAD (mm)
n = 73
14.1 ± 1.59 15.4 ± 2.7 .022
LA/Ao
n = 73
1.23 ± 0.20 1.32 ± 0.27 .093
LAFS (%)
n = 73
33.2 ± 5.6 28.8 ± 7.5 .006
LVFS (%)
n = 73
48.5 ± 7.4 54.2 ± 10.1 .008
LVEF (%)
n = 73
63.4 ± 8.5 65.3 ± 12.1 .45
MAPSE FW (mm)
n = 73
5.5 ± 1.0 4.1 ± 0.8 <.001
MAPSE IVS (mm)
n = 73
5.1 ± 0.9 4.2 ± 0.9 <.001
TAPSE (mm)
n = 72
8.7 ± 1.7 7.9 ± 1.4 .028
LV mass (gr)
n = 73
8.6 ± 2.7 13.2 ± 3.7 <.001
Abbreviations: IVSd, mean end-diastolic interventricular septal thickness;
LA:Ao, left atrium to aorta ratio; LAD, left atrial diameter in long axis;
LAFS, left atrial fractional shortening; LVEF, left ventricular ejection
fraction; LVFS, left ventricular fractional shortening; LVFWd, mean
end-diastolic left ventricular wall thickness; LVIDd, end diastolic left
ventricular internal diameter; MAPSE FW, mitral annular plane systolic
excursion measured at the free wall; MAPSE IVS, mitral annular plane
systolic excursion measured at the interventricular septum; maxIVSd,
maximal end-diastolic interventricular septal thickness; maxLVFWd,
maximal end-diastolic left ventricular wall thickness; N/A, statistical
analysis not applicable (criteria used for the classification into
healthy/HCM); RVd, end diastolic right ventricular wall thickness; TAPSE,
tricuspid annular plane systolic excursion; LV mass, end diastolic left
ventricular mass.
Data are presented as mean ± SD. Independent t-test analysis was
performed to identify difference between groups.
TABLE 4 Speckle-tracking echocardiography (STE) variables
STE
Healthy
controls
(n = 36 for all
observations
except for
RV S/SR)
HCM
(n =37 for all
observations
except for
RV S/SR)
P value
for between
group
comparisons
Circumferential S (%) −23.2 ± 3.9 −21.2 ± 6.2 .12
Circumferential S (%)
IVS −22.4 ± 5.2 −19.2 ± 6.5
FW −23.9 ± 4.4 −23.3 ± 7.2
Circumferential SR (s−1) −3.84 ± 0.94 −3.73 ± 1.01 .25
Circumferential SR (s−1)
IVS −3.75 ± 1.03 −3.58 ± 1.23
FW −4.01 ± 0.99 −3.9 ± 0.95
Radial S (%) 66.7 ± 17.6 44.0 ± 21.3 <.001
Radial S (%)
IVS 67.6 ± 18.5 44.3 ± 19.7
FW 65.9 ± 17.5 43.7 ± 18.3
Radial SR (s−1) 6.67 ± 1.8 5.6 ± 2.08 .022
Radial SR (s−1)
IVS 6.56 ± 1.79 5.68 ± 2.45
FW 6.80 ± 1.86 5.53 ± 1.86
Longitudinal S (%) −19.7 ± 2.74 −14.8 ± 3.3 <.001
Longitudinal S (%)
IVS −23.1 ± 3.3 −17.9 ± 3.9
FW −16.22 ± 3.5 −11.7 ± 4.3
Longitudinal SR (s−1) −2.9 ± 0.68 −2.36 ± 0.62 <.001
Longitudinal SR (s−1)
IVS −3.32 ± 0.81 −2.79 ± 0.75
FW −2.60 ± 0.78 −1.94 ± 0.66
RV Longitudinal S (%) −26.2 ± 5.4 −26.7 ± 6.0 .76
(n = 48) (n = 24) (n = 24)
RV Longitudinal SR (s−1) −4.17 ± 0.88 −4.66 ± 0.88 .30
(n = 48) (n = 24) (n = 24)
Abbreviations: Circumferential S, circumferential strain; Circumferential
SR, circumferential strain rate; longitudinal S, left ventricular longitudinal
strain; longitudinal SR, left ventricular longitudinal strain rate; Radial S,
radial strain, Radial SR, radial strain rate; RV longitudinal S, right
ventricular strain, RV longitudinal SR, right ventricular strain rate.
Data are presented as mean ± SD.
Independent t-test analysis was performed to identify difference between
groups.
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Twenty-eight cats with preclinical HCM had dynamic left ventric-
ular outflow tract obstruction. When evaluating echocardiographic
data, cats with HCM had increased left atrial diameter in long axis
(LAD, P= .002), LVFS (P = .008), and LV mass (P < .001) compared to
healthy controls. Furthermore, cats with HCM had lower LAFS
(P = .006), MAPSE IVS (P < .001), MAPSE FW (P< .001), and TAPSE
(P = .028) compared to healthy control cats (Table 3). When com-
pared to normal cats, cats with HCM had lower radial S (P < .001)
and SR (P= .022) and less negative longitudinal S (P < .001) and SR
(P < .001) (Table 4), whereas no difference was observed for circum-
ferential S (P = .12) and SR (P = .25) or RV longitudinal S (P= .76) and
SR (P= .30).
When analyzing correlations between STE and left ventricular
hypertrophy, Pearson correlation's coefficient showed moderate cor-
relation between maximal IVS and FW thickness and the respective
global IVS and FW longitudinal S (r=0.659, P< .001 and r=0.524,
P< .001), moderate correlation between maximal IVS and FW and the
respective global IVS and FW radial strain (r=−0.494, P< .001 and
r=−0.413, P< .001). Weak correlation was observed for maximal IVS
and FW thickness and the respective global IVS and FW longitudinal
SR (r= 0.327, P= .005 and r=0.371, P= .001) as well as maximal IVS
and global IVS circumferential S (r=0.307, P= .008).
Left ventricular mass was strongly correlated with IVSd and
LVFWd (r= 0.701, P < .001 and r = 0.715, P < .001 respectively). Addi-
tionally, LV mass moderately correlated with longitudinal S and SR
(r= 0.511, P< .001 and r = 0.311, P = .007, respectively), but not with
other STE-derived variables. No significant correlation was found
between body weight and LV mass or longitudinal S or SR. No signif-
icant correlation was found between heart rate and STE-derived
variables.
When assessing the predictive ability of STE-derived variables,
LV mass and standard echocardiographic variables, the ROC curves
showed that LV mass, and longitudinal S had some of the highest
AUCs of 0.867 (CI: 0.783-0.951) and 0.862, respectively (CI:0.781-0.943)
(Figure 2, Table 5). Based on the Youden Index, the best cutoff for LV
mass was 10 g (Youden Index 0.62) and−15.9% for Long S (Youden index
0.56).
The final logistic regression model showed that LV mass, MAPSE
FW, and LVIDd in combination best predicted the presence of HCM
(Table 6).
The combination of these tests increased the probability of a cat
with HCM to be correctly classified as affected (predicted ROC curve,
AUC 0.974, CI 0.945-1.000) (Figure 2).
F IGURE 2 ROC curve constructed using probabilities derived
from the binary logistic regression and selected echocardiographic
variables to differentiate asymptomatic cats from those with HCM.
The 4 individual echocardiographic variables with the greatest areas
under the curve are plotted in addition to the predicted probabilities
from the regression equation. The gold standard was 2-dimensional
left ventricular wall thickness. The area under the curve with 95%
confidence interval values is displayed in Table 5. Predicted
probability, derived from binary logistic regression model; LV mass
truncated ellipsoid, end-diastolic left ventricular mass measured by
the truncated ellipse method; longitudinal S, left ventricular
longitudinal strain; MAPSE FW, mitral annular plane systolic excursion
measured at the free wall; LVIDd, end diastolic left ventricular internal
diameter
TABLE 5 Output from ROC curves
Variable
Area under the
curve (AUC) 95% CI
Predicted model 0.974 0.945-1.000
LV mass 0.867 0.783-0.951
MAPSE FW 0.864 0.781-0.947
Longitudinal S 0.862 0.781-0.943
LVIDd 0.827 0.734-0.921
RVd 0.803 0.699-0.907
Radial S 0.788 0.682-0.895
MAPSE IVS 0.784 0.638-0.858
Longitudinal SR 0.751 0.639-0.862
LAFS 0.681 0.556-0.805
LVFS 0.673 0.548-0.798
Radial SR 0.655 0.528-0.782
LAD 0.651 0.523-0.779
TAPSE 0.627 0.495-0.758
LA/Ao 0.610 0.480-0.741
EF 0.584 0.450-0.718
Circumferential S 0.577 0.444-0.710
Circumferential SR 0.521 0.387-0.655
RV Longitudinal S 0.483 0.319-0.648
RV Longitudinal SR 0.446 0.282-0.611
Output from ROC curves for echocardiographic variables and predicted
probabilities obtained from multivariable logistic regression analysis. Area
under the curve (AUC) and 95% confident interval (CI) are provided.
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4 | DISCUSSION
The results of the present study showed that in 2 groups of cats of
similar age, sex, weight, body condition score, and heart rate, cats with
preclinical HCM had lower absolute values of both longitudinal and
radial S and SR, and greater LV mass. Furthermore, a correlation was
found between regional IVS or FW longitudinal S and regional LV wall
thickness, as well as between longitudinal S or SR and LV mass. In the
study population, these variables performed well individually at differ-
entiating cats with preclinical HCM from controls when compared to
standard echocardiographic variables. The logistic regression model
that best predicted the presence of HCM included a combination of
LV mass, MAPSE FW, and LVIDd. Within-day and between-day CV
was acceptable and similar to previous studies,34,35,43 with global S
and SR values achieving better reproducibility than regional measure-
ments, as identified in a previous study on S/SR.43
Studies on myocardial fiber distribution showed that the myocar-
dium has longitudinally and circumferentially oriented fibers, which
support cardiac contraction in different deformation planes.44Short
axis, long axis, and twist represent deformation planes that contribute
to cardiac ejection.22 LVFS can be considered a surrogate of short axis
deformation, as well as circumferential and radial S and SR. Long axis
function can be identified by atrioventricular systolic plane excursion
(MAPSE), as during contraction the cardiac base descends toward the
cardiac apex45; longitudinal S and SR are also additional long axis
deformation variables. The right ventricle has mainly longitudinally ori-
ented fibers, with minimal short axis deformation, therefore TAPSE
and longitudinal S and SR are the deformation variables that can be
used to assess right ventricular deformation. Torsion and twist are an
additional feature of the contracting heart, as the heart base and apex
counter-rotate to allow twisting of the left ventricle to aid ejection.
STE allows the evaluation of myocardial deformation in different
planes and is an echocardiography-based technique.21,22 As with
every technique, there are limitations, which for STE are mainly
related to image quality, out of plane motion, and load dependency.21
Additional limitations include a steep learning curve, inter-vendor
software analysis variation and an overall acceptable CV, mainly with
global results, yet regional segment analysis can have greater variation
(up to 16% of variation).43 The present study included cases seen at
the authors' outpatient clinic, and the required cine loops were not
different from the standard views required for a standard echocardio-
gram. It is important to take particular care with image quality,
symmetry and in limiting out-of-plane motion to allow STE analysis
and this technique might therefore be difficult in uncooperative or
critically ill cats.
The results of our study showed that longitudinal deformation is
impaired early in the disease, similar to previous reports in people
with preclinical HCM13–17 where early impairment in longitudinal and
radial S and SR has been observed, whereas circumferential S and SR
tend to be preserved or increased, with some studies reporting deteri-
oration of the circumferential deformation as a possible explanation
for the development of clinical signs.12,14,16
Previous studies assessing STE in cats with HCM showed discor-
dant results. One study did not identify any change in longitudinal sys-
tolic S or SR, with the only abnormality detected being a diastolic
change in longitudinal E and A SR, but not its ratio.18 The cat popula-
tion was relatively homogeneous and no cat received treatment.
However, sample size was smaller than our study, and the degree of
hypertrophy was mild, which might account for the differences in the
results. Also, no segmental S or SR data were shown, and only global
values were presented. In the present study, diastolic SR analysis was
not performed so it is not possible to fully compare our study to those
previously published. Another study reported decreased radial and
longitudinal systolic S and SR in cats with HCM not showing clinical
signs and with congestive heart failure, but not in those showing
clinical signs other than CHF (exercise intolerance, dyspnea or
tachypnea).19 The multiple subgroups with low number of cats in each
group could have limited statistical power. No characterization on
hypertrophy distribution and regional mechanics was mentioned in
that study,19 and cardiac therapy was allowed. Our results confirm the
previous observation that cats with asymptomatic HCM have lower
absolute values of longitudinal and radial deformation compared to
healthy cats. A more recent study identified preserved endocardial
circumferential strain but lower epicardial values resulting in greater
epicardial to endocardial ratio in cats with dynamic outflow tract
obstruction and HCM,36 so it could be that more detailed analysis of
circumferential deformation would be required in the assessment of
cats with HCM. Compared with healthy control cats, the cats with
preclinical HCM in our study had decreased longitudinal and radial
deformation with similar circumferential S and SR, that was assessed
at the mid-myocardium level, in contrast to the previously cited
study,36 where the whole layer circumferential results were lower in
asymptomatic cats with HCM, but were not statistically different on a
previous study from the same group.19 There are similar discrepancies
TABLE 6 Binary logistic regression analysis results
Parameter B value OR CI Wald P value
LV mass 0.792 2.207 1.435-3.395 12.99 <.001
LVIDd −0.681 0.506 0.287-0.891 5.569 =.018
MAPSE FW −1.524 0.218 0.060-0.792 5.352 =.021
Constant 8.385 4381.982 5.057 =.025
Abbreviations: B value, beta value coefficient; CI, confident interval; LV mass, end diastolic left ventricular mass; LVIDd, end diastolic left ventricular
internal diameter; OR, odds ratio; MAPSE FW, mitral annular plane systolic excursion measured at the free wall, which were all statistically significant in
the model; Wald, wald test result.
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in circumferential S and SR in humans12,14,16 and there is currently
interest in the assessment of a transmural strain difference both on
MRI and echocardiography46,47 in human cardiology.
The best correlation with regional hypertrophy and left ventricular
mass was observed with longitudinal S and SR. No weight-dependence
was identified in the present study in STE-derived values, although the
weight range in our group of cats was relatively narrow, with few cats
weighing more than 5 kg or less than 3 kg. A similar lack of correlation
between LV mass and bodyweight was also observed. The present find-
ings suggest that in this population of cats, STE and LV mass can pro-
vide a weightless index to aid in the characterization of HCM; however,
further studies are required to elucidate if a wider body weight range
would impact LV mass and STE variables based on the findings of
increasing LV wall thickness with increasing body weight.48
LV mass has been quantified by MRI, echocardiography and post-
mortem in cats37; however, no extensive use of this technique has been
applied in veterinary medicine. To the author's knowledge, no repeat-
ability studies in the veterinary literature are available. Different LV
mass calculations in people are available, including M-mode and 2D
based calculations. The truncated ellipse method is the 2-dimensional
method recommended in human guidelines39 and previously applied in
cats.37 It requires both short- and long-axis views, but an overall
acceptable correlation was found compared to post-mortem LV mass
assessment in cats, although MRI-based mass calculation correlated
better to actual LV mass.37 Healthy control cats in our study had similar
values to the ones reported previously.37Longitudinal S and SR seemed
to correlate well with LV mass, with less negative longitudinal S values
associated with increasing LV mass. There is similar correlation in peo-
ple with HCM.12,14
Early diagnosis and risk stratification are important targets in
human medicine in order to deliver the best treatment options. A
decrease in longitudinal S has been associated with a poorer prognosis
in people, with the highest incidence of adverse events (including con-
gestive heart failure, ventricular tachycardia, sudden cardiac death or
the implantation of a cardiodefibrillator device) with lower absolute
values (ie, less negative results).49 A longitudinal S greater than −16%
(ie, less negative) was an independent predictor of adverse effects in
people.50 Longitudinal S could be of help in classifying equivocal or
challenging cases or allow a closer monitoring over time; however,
longitudinal studies are required to investigate this aspect. Because of
the previously reported limitations in the technique and the results of
our regression analysis, MAPSE seems to be a more widely applicable
alternative in the assessment of longitudinal deformation, with the
main limitation of this technique associated with the specific regional
sampling required (atrioventricular annulus and not a global index of
longitudinal deformation).
The logistic regression model that showed the best association
with a diagnosis of HCM in our population combined LV mass,
MAPSE FW, and LVIDd. When left ventricular hypertrophy is mani-
fest, left ventricular wall thickness is likely sufficient to discriminate
between affected and non-affected. However, combining different
variables could help in settings where the hypertrophy is not as obvi-
ous, such as in equivocal cases or in cats with a family history of
HCM. Interestingly, the 3 variables that were shown to increase the
probability of a cat to have HCM include a marker of global wall thick-
ness (LV mass), LV chamber size, and longitudinal deformation. This
might indicate that alongside wall thickness, LV geometry and func-
tion are additional tools that could aid identifying HCM or improve
monitoring. This potential application requires further investigation.
Longitudinal observational studies in cats with preclinical HCM and
with equivocal HCM might provide insight into the applicability of lon-
gitudinal S or MAPSE and LV mass as an aid in risk stratification for
HCM development or progression. Genotype-positive and phenotype-
negative people represent a challenge in human cardiology, and few
studies have investigated abnormalities using advanced echocardio-
graphic techniques.27,28 Maine Coon cats heterozygous for the muta-
tion A31P do not always show LV hypertrophy51–55 but the prevalence
of hypertrophy increases with age53,55 so use of a combined predictive
model would be worth evaluating in this context.
As expected, cats with HCM had thicker end-diastolic RV wall
thicknesses values as previously identfied.56,57 Interestingly, in the
asymptomatic phase, no difference in RV Long S and SR was observed.
TAPSE values are lower in cats with CHF, so it could be possible that
RV global long axis deformation is impaired later on, when clinical signs
develop or when there is an increase in pulmonary arterial pressure or
pulmonary hypertension.58
Limitations of the present study include its retrospective nature;
however, a standardized protocol for clinical cats and healthy controls
was applied. It was not possible to blind the operator to the presence
of LV hypertrophy when making echocardiographic measurements,
and our study did not address diastolic function deformation via stan-
dard echocardiography or STE, or torsion or twist. Variability of right
ventricular shape makes RV imaging more challenging; where avail-
able, the authors used RV focused views; otherwise, RV S and SR
were not assessed. Our study was not designed to assess genotype.
The classification and ROC curve output was based on a 2D end-
diastolic LV wall thickness cutoff of 6 mm, which is considered a con-
servative cutoff for the diagnosis of HCM in cats, it is possible that
other cutoffs could be better at classifying HCM in cats. Furthermore,
the authors cannot exclude that the healthy cats group might have
included cats with preclinical HCM not meeting the current criteria
for HCM. Additionally, the regression model was performed in a
dichotomous population of cats, where LV hypertrophy was manifest or
absent based on the selected cutoff, so the results of this model might
not be readily applied in a population of cats with equivocal/genotype
positive-phenotype negative cats, for which a longitudinal study would
be required.
In conclusion, cats with HCM had decreased systolic long axis
deformation and radial deformation, but overall preserved circumfer-
ential deformation. Left ventricular mass was increased in cats with
HCM. LV mass and longitudinal S correlated with the degree of left
ventricular hypertrophy and performed best when compared to stan-
dard echocardiographic variables. STE CV was acceptable, with the
lowest CV with global S and SR. Longitudinal S and LV mass might be
useful additional variables in the evaluation of cats with HCM.
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